MedPath

Spyglass DS Peroral Cholangioscope Guided LL or EHL Versus BML for Endoscopic Removal of Complicated Bile Duct Stones

Not Applicable
Recruiting
Conditions
Biliary Stones
Interventions
Device: Spyglass DS cholangioscope
Device: BML
Registration Number
NCT03244163
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

This study aims to compare the overall rate of endoscopic clearance of complicated bile duct stones by Spyglass DS peroral cholangioscopy guided holmium:YAG laser/electrohydraulic lithotripsy versus conventional BML.

Detailed Description

Currently, complicated bile duct stones are removed during endoscopic retrograde cholangiopancreatography (ERCP) by conventional mechanical lithotripsy, which means using a metal wire basket to capture the stone and crush it to make it easier to remove. This is successful in approximately 70% of patients, with the success rate inversely correlated to the size of the stone. Unsuccessful stone removal would require additional endoscopic, percutaneous or surgical interventions. Spyglass DS peroral cholangioscope-guided holmium:YAG laser/electrohydraulic lithotripsy is a recent alternate method for managing complicated bile duct stones. Also performed during ERCP, a thin flexible camera (called Spyglass DS peroral cholangioscope) is inserted into the bile duct to visualize the stone which can then be targeted by a laser beam for fragmentation (also known as laser lithotripsy). The smaller pieces are then removed. Direct comparisons of these procedures' efficacy however have not been performed.

The purpose of this study is to compare the efficacy and safety of Spyglass DS peroral cholangioscope-guided holmium:YAG laser/electrohydraulic lithotripsy (the laser arm) versus conventional basket mechanical lithotripsy alone (the conventional arm) for fragmentation and clearance of complicated bile duct stones.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Patients with complicated biliary stones
  • Patients older than 18 years old
  • Patients where informed consent can be obtained
Read More
Exclusion Criteria
  • Patients who cannot give informed consent
  • Patients under 18 years old
  • Pregnant or lactating patients
  • Patient with altered gastrointestinal/biliary anatomy
  • Patients with distal CBD malignant stricture from intrinsic or extrinsic causes
  • Patients with ongoing cholangitis or biliary pancreatitis
  • Patient with refractory bleeding tendencies (Platelet count <50,000/mm3 or International Normalized Ratio >1.5 despite correction with platelet or fresh frozen plasma transfusions)
  • Patients with intrahepatic segmental stones
  • Patients with contraindications to endoscopy due to comorbidities
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LASER ARMSpyglass DS cholangioscopeSpyglass DS cholangioscope guided laser or electrohydraulic lithotripsy
CONVENTIONAL ARMBMLStone removal by conventional techniques, for example BML, without laser lithotripsy
Primary Outcome Measures
NameTimeMethod
Overall rate of endoscopic bile duct stone clearanceIntraoperative

Overall rate of endoscopic bile duct stone clearance

Secondary Outcome Measures
NameTimeMethod
Incidence of adverse events30 days

Incidence of adverse events

Technical feasibilityIntraoperative

Technical feasibility defined as successful introduction of cholangioscope into the CBD, visualisation and laser targeting of stone

Need for and number of additional procedures for stone clearance6 months

Need for and number of additional procedures for stone clearance

Trial Locations

Locations (1)

Endoscopy Centre, Prince of Wales Hospital

🇭🇰

Hong Kong, NT, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath